西村 剛志

Corrigendum tonode ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma" [Auris Nasus Larynx (2018) Aug;45(4):846-853]. "Lymph 

Auris, nasus, larynx 46(5) 818-819 2019年10月  査読有り

Predictive value of the Hyodo score in endoscopic evaluation of aspiration during swallowing. 

Auris, nasus, larynx 45(6) 1214-1220 2018年12月  査読有り

Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial. 

JMIR research protocols 7(8) e11003 2018年8月23日  査読有り

Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma. 

Auris, nasus, larynx 45(4) 846-853 2018年8月  査読有り

The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study. 

Auris, nasus, larynx 45(3) 558-565 2018年6月  査読有り

Cochlear volume as a predictive factor for residual-hearing preservation after conventional cochlear implantation. 

Acta oto-laryngologica 138(4) 345-350 2018年4月  査読有り

The Second-Look Procedure for Transoral Videolaryngoscopic Surgery for T1 and T2 Laryngeal, Oropharyngeal, and Hypopharyngeal Cancer Patients: Protocol for a Nonrandomized Clinical Trial. 

JMIR research protocols 6(12) e235 2017年12月5日  査読有り

Efficacy and safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel for high-risk head and neck cancer patients in Japan 

CANCER CHEMOTHERAPY AND PHARMACOLOGY 80(1) 203-207 2017年7月  査読有り

Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer 

LARYNGOSCOPE 127(4) 862-867 2017年4月  査読有り

Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapy. 

Head & neck 38(11) 1666-1671 2016年11月  査読有り

Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy 

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 21(5) 869-874 2016年10月  査読有り

Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma. 

International journal of clinical oncology 21(4) 658-667 2016年8月  査読有り

Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma. 

Cancer chemotherapy and pharmacology 77(6) 1315-9 2016年6月  査読有り

Antitumor effects of IDN5109 on head and neck squamous cell carcinoma (vol 15, pg 329, 2006) 

ONCOLOGY REPORTS 35(4) 2494-2494 2016年4月  査読有り

Diagnostic sensitivity of ¹⁸fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients. 

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 269(5) 1503-1507 2012年5月  査読有り

Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma. 

Anticancer research 32(2) 595-600 2012年2月  査読有り

Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma 

AURIS NASUS LARYNX 38(6) 724-729 2011年12月  査読有り

Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma 

CANCER CHEMOTHERAPY AND PHARMACOLOGY 68(4) 855-862 2011年10月  査読有り

Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities. 

Cancer science 102(9) 1717-23 2011年9月  査読有り